US 7064141
Method for preventing, treating or inhibiting development of simple retinopathy and preproliferative retinopathy
granted A61KA61K31/00A61K31/41
Quick answer
US patent 7064141 (Method for preventing, treating or inhibiting development of simple retinopathy and preproliferative retinopathy) held by Takeda Pharmaceutical Company Limited expires Mon Jun 15 2026 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Takeda Pharmaceutical Company Limited
- Grant date
- Tue Jun 20 2006 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jun 15 2026 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 2
- CPC classes
- A61K, A61K31/00, A61K31/41, A61K31/4178, A61K31/4184